S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
OTCMKTS:PETV

PetVivo Stock Forecast, Price & News

$2.50
-0.14 (-5.30 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.41
$2.59
50-Day Range
$2.40
$8.50
52-Week Range
$2.36
$17.00
Volume77,015 shs
Average Volume180,606 shs
Market Capitalization$24.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.61
30 days | 90 days | 365 days | Advanced Chart
Receive PETV News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.


PetVivo logo

About PetVivo

PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PETV
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
$10,000.00
Book Value
($0.13) per share

Profitability

Net Income
$-3.52 million
Net Margins
-21,333.33%

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$24.12 million
Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

2.11 out of 5 stars

Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.0 5 -4 -3 -2 -1 -












PetVivo (OTCMKTS:PETV) Frequently Asked Questions

Is PetVivo a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetVivo in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" PetVivo stock.
View analyst ratings for PetVivo
or view top-rated stocks.

What stocks does MarketBeat like better than PetVivo?

Wall Street analysts have given PetVivo a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but PetVivo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were PetVivo's earnings last quarter?

PetVivo Holdings, Inc. (OTCMKTS:PETV) posted its quarterly earnings data on Monday, August, 16th. The company reported ($0.07) earnings per share (EPS) for the quarter.
View PetVivo's earnings history
.

How has PetVivo's stock price been impacted by Coronavirus?

PetVivo's stock was trading at $0.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PETV stock has increased by 594.4% and is now trading at $2.50.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for PETV?

1 analysts have issued twelve-month price objectives for PetVivo's stock. Their forecasts range from $7.00 to $7.00. On average, they anticipate PetVivo's stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 180.0% from the stock's current price.
View analysts' price targets for PetVivo
or view top-rated stocks among Wall Street analysts.

Who are PetVivo's key executives?

PetVivo's management team includes the following people:
  • John Lai, President, Chief Executive Officer & Director
  • Randall A. Meyer, Chief Operating Officer & Director
  • Robert J. Folkes, Chief Financial Officer
  • David B. Masters, Director, Director-Science & Technology
  • John F. Dolan, Secretary, Director & General Counsel

What is PetVivo's stock symbol?

PetVivo trades on the OTCMKTS under the ticker symbol "PETV."

Who are PetVivo's major shareholders?

PetVivo's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Asset Dedication LLC (0.30%). Company insiders that own PetVivo stock include James Joseph Martin, James Rudolph Martin, Robert J Folkes and Scott Mitchell Johnson.
View institutional ownership trends for PetVivo
.

Which institutional investors are buying PetVivo stock?

PETV stock was purchased by a variety of institutional investors in the last quarter, including Asset Dedication LLC. Company insiders that have bought PetVivo stock in the last two years include James Joseph Martin, James Rudolph Martin, Robert J Folkes, and Scott Mitchell Johnson.
View insider buying and selling activity for PetVivo
or or view top insider-buying stocks.

How do I buy shares of PetVivo?

Shares of PETV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetVivo's stock price today?

One share of PETV stock can currently be purchased for approximately $2.50.

How much money does PetVivo make?

PetVivo has a market capitalization of $24.12 million and generates $10,000.00 in revenue each year.

How many employees does PetVivo have?

PetVivo employs 2 workers across the globe.

What is PetVivo's official website?

The official website for PetVivo is www.petvivo.com.

Where are PetVivo's headquarters?

PetVivo is headquartered at 5251 EDINA INDUSTRIAL BLVD, EDINA MN, 55439.

How can I contact PetVivo?

PetVivo's mailing address is 5251 EDINA INDUSTRIAL BLVD, EDINA MN, 55439. The company can be reached via phone at (952) 405-6216.


This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.